Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H6N2O2 |
Molecular Weight | 210.1882 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1C(=O)C2=C(C=CC=N2)C3=C1N=CC=C3
InChI
InChIKey=VLPADTBFADIFKG-UHFFFAOYSA-N
InChI=1S/C12H6N2O2/c15-11-9-7(3-1-5-13-9)8-4-2-6-14-10(8)12(11)16/h1-6H
Molecular Formula | C12H6N2O2 |
Molecular Weight | 210.1882 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Phanquone is an orthoquinone that is the 5,6-diketo derivative of 4,7-phenanthroline. It derives from a hydride of a 4,7-phenanthroline. Phanquone (Entobex) is an anti-mycotic drug with anti-protozoal activity. Phanquone is active against a wide range of Gram-positive and Gram-negative organisms. Phanquone partically inhibited oxygen consumption by Escherichia coli and Staphylococcus aureus. It was also tried on cases of rheumatoid diseases.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
HPLC-fluorescence determination of amino acids in pharmaceuticals after pre-column derivatization with phanquinone. | 2004 Apr 16 |
|
Development and validation of a HPLC method for 4,7-phenanthroline-5,6-dione I and identification of its major impurity by HPLC-MS-APCI. | 2005 Apr |
|
LC determination of leuprolide component amino acids in injectable solution by phanquinone pre-column derivatization labelling procedure. | 2005 Apr 29 |
|
Phanquinone as a suitable derivatization reagent in micellar electrokinetic chromatography and HPLC analysis of amino acids. | 2006 Jun |
|
Ruthenium(II) coordination chemistry of a fused donor-acceptor ligand: synthesis, characterization, and photoinduced electron-transfer reactions of [{Ru(bpy)2}(n)(TTF-ppb)](PF6)(2n) (n = 1, 2). | 2008 Dec 1 |
|
Liquid chromatographic fluorescence determination of amino acids in plasma and urine after derivatization with phanquinone. | 2008 Feb |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://patents.google.com/patent/US4183941
Phanquone (entobex) was given in doses of 100 mg. twice daily by mouth for seven days, repeated at intervals of a week
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6236746
Phanquone inhibited E.coli 205 growth with MIC =1 ug/ml
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:05:53 GMT 2023
by
admin
on
Fri Dec 15 15:05:53 GMT 2023
|
Record UNII |
ID94IS6N8J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Official Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C277
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
||
|
WHO-VATC |
QP51AX03
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
||
|
WHO-ATC |
P01AX04
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3433
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY | |||
|
100000082225
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY | |||
|
PHANQUINONE
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY | |||
|
m8582
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID3046112
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY | |||
|
C90620
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY | |||
|
924
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY | |||
|
ID94IS6N8J
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY | |||
|
C004902
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY | |||
|
SUB09742MIG
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY | |||
|
84-12-8
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY | |||
|
201-516-0
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY | |||
|
6764
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY | |||
|
DB13469
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY | |||
|
59141
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY | |||
|
CHEMBL531048
Created by
admin on Fri Dec 15 15:05:53 GMT 2023 , Edited by admin on Fri Dec 15 15:05:53 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |